Skip to main content
Clinical Trials/NCT06073145
NCT06073145
Completed
Not Applicable

Non-invasive Monitoring of Blood Flow in the Brain by Using a Wearable Ultrasound Patch

University of California, San Diego1 site in 1 country36 target enrollmentSeptember 27, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Medical Device Complication
Sponsor
University of California, San Diego
Enrollment
36
Locations
1
Primary Endpoint
Device comparison to standard monitoring (conventional transcranial Doppler)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The main objective of this research is to measure the Doppler signal by the ultrasonic patch. Blood flow measurement is critical for vasospasm, stroke, and embolism monitoring on patients in the ICU or understanding the neurovascular coupling on different subjects. Currently, A conventional transcranial Doppler (TCD) probe is widely used for these applications. A headset design must be applied and fixed on the participants to obtain stable blood flow spectra. However, the TCD headset is operator dependent. The operator needs to be a trained expert and hold the ultrasound probe to get accurate blood flow velocity information. The stretchable and wearable non-invasive ultrasonic patch can not only free the operator's hands but can also provide long-term continuous monitoring, which is not possible by using the current operator-dependent ultrasound machine. The device can be conformal to the skin and attached to the skin surface.

Registry
clinicaltrials.gov
Start Date
September 27, 2022
End Date
April 8, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sheng Xu

Associate Professor

University of California, San Diego

Eligibility Criteria

Inclusion Criteria

  • Able to provide informed consent.
  • In relatively good health with no serious medical conditions.

Exclusion Criteria

  • Inability to sign the informed consent.
  • History of the following conditions: Heart attack, low blood pressure, aortic stenosis/carotid artery stenosis (also known as heart valve disease), glaucoma (a group of eye conditions that damage the optic nerve) or retinopathy (a disease of the eye retina).

Outcomes

Primary Outcomes

Device comparison to standard monitoring (conventional transcranial Doppler)

Time Frame: 1.5 years

Clinical feasibility of the measurements from the non-invasive ultrasound patch in comparison to a conventional transcranial Doppler probe on 60 participants. Specifically, the blood flow specturm of different arterial segments including middle cerebral artery, anterior cerebral artery, posterior cerebral artery, vertebral artery, basal artery, internal carotid artery, and ophthalmic artery will be measured by the wearable ultrasound patch and the conventional transcranial Doppler probe. The agreement of these two device on peak systolic velocity, mean flow velocity, and end diastolic velocity of the measurements will be evaulated using the Bland-Altman plot.

Study Sites (1)

Loading locations...

Similar Trials